Trials / Completed
CompletedNCT00097526
Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
Bone Mineral Density in Adolescent Subjects With Growth Hormone Deficiency Who Are Completing Treatment With Nutropin AQ, Nutropin, or Protropin in the National Cooperative Growth Study (NCGS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 125 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, open-label, postmarketing surveillance study. The substudy will collect information on BMD in adolescents and young adults with GHD or Turner syndrome who are completing GH treatment for statural indications.
Conditions
Timeline
- Start date
- 2000-04-01
- Primary completion
- 2010-07-01
- Completion
- 2010-07-01
- First posted
- 2004-11-25
- Last updated
- 2012-11-14
Source: ClinicalTrials.gov record NCT00097526. Inclusion in this directory is not an endorsement.